High-Risk Alcohol Use Is Associated With Significantly Greater Risk of Incident Hepatocellular Carcinoma in a National Cohort of US Veterans With Metabolic Dysfunction Associated Fatty Liver Disease

被引：0
|
作者：
Wong, Robert J. [1 ,2 ]
Yang, Zeyuan [2 ]
Cheung, Ramsey [1 ]
Singal, Ashwani K. [3 ]
Do, Albert [4 ]
Ahmed, Aijaz [5 ]
Yeoh, Aaron [5 ]
机构：
[1] Stanford Vet Affairs Palo Alto, Palo Alto, CA USA
[2] Vet Affairs Palo Alto, Palo Alto, CA USA
[3] Univ South Dakota, Sioux Falls, SD USA
[4] Yale Sch Med, New Haven, CT USA
[5] Stanford, Stanford, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1360
引用
收藏
页码：S1043 / S1043
页数：1
相关论文
共 50 条
  • [41] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Uehara, Tatsuki
    Wakui, Hiromichi
    Tamura, Kouichi
    HYPERTENSION RESEARCH, 2023, 46 (05) : 1165 - 1167
  • [42] Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus
    Miyake, Teruki
    Matsuura, Bunzo
    Furukawa, Shinya
    Ishihara, Toru
    Yoshida, Osamu
    Miyazaki, Masumi
    Watanebe, Kyoko
    Shiomi, Akihito
    Nakaguchi, Hironobu
    Yamamoto, Yasunori
    Koizumi, Yohei
    Tokumoto, Yoshio
    Hirooka, Masashi
    Takeshita, Eiji
    Kumagi, Teru
    Abe, Masanori
    Ikeda, Yoshio
    Iwata, Takeru
    Hiasa, Yoichi
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (07) : 1245 - 1252
  • [43] NONCIRRHOTIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE INCREASES RISK OF HEPATOCELLULAR CARCINOMA AND NEW CIRRHOSIS, AND OVERALL DEATH COMPARED TO OTHER LIVER DISEASES AMONG US VETERANS
    Puri, Puneet
    Thuy-Duyen Vu
    Aggarwal, Vinod
    Gilles, HoChong
    Fuchs, Michael
    HEPATOLOGY, 2024, 80 : S877 - S878
  • [44] Impact of metabolic phenotype and alcohol consumption on mortality risk in metabolic dysfunction-associated fatty liver disease: a population-based cohort study
    Charatcharoenwitthaya, Phunchai
    Karaketklang, Khemajira
    Aekplakorn, Wichai
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE INCREASES COLON CANCER RISK: A NATIONWIDE COHORT STUDY
    Lee, Hye Won
    Kim, Seung Up
    GUT, 2021, 70 : A10 - A11
  • [46] Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study
    Chang, Qing
    Zhang, Yixiao
    Zhang, Tingjing
    Liu, Zuyun
    Cao, Limin
    Zhang, Qing
    Liu, Li
    Sun, Shaomei
    Wang, Xing
    Zhou, Ming
    Jia, Qiyu
    Song, Kun
    Ding, Yang
    Zhao, Yuhong
    Niu, Kaijun
    Xia, Yang
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
  • [47] Metabolic Dysfunction-Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study
    Lee, Hokyou
    Lee, Hye Won
    Kim, Seung Up
    Kim, Hyeon Chang
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (01) : E00435
  • [48] Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study
    Heo, Ji Hye
    Lee, Mi Yeon
    Kim, Seong Hwan
    Zheng, Ming-Hua
    Byrne, Christopher D.
    Targher, Giovanni
    Sung, Ki-Chul
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (05)
  • [49] Progression of liver disease and associated risk of hepatocellular carcinoma
    Poli, Edoardo
    De Martin, Eleonora
    HEPATOMA RESEARCH, 2024, 10
  • [50] PILOT INTERVENTION FOR THE EARLY DETECTION OF LIVER DISEASE IN VETERANS WITH HIGH-RISK ALCOHOL USE
    Hsu, Cynthia L.
    Soltani, Maryam
    Patton, Heather
    GASTROENTEROLOGY, 2022, 162 (07) : S1145 - S1146
12345